BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng F, Zhang Y, Han X, Zeng M, Gao Y, Weng J. Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma. Comput Struct Biotechnol J 2021;19:2775-89. [PMID: 34093992 DOI: 10.1016/j.csbj.2021.03.033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Abou Khouzam R, Zaarour RF, Brodaczewska K, Azakir B, Venkatesh GH, Thiery J, Terry S, Chouaib S. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? Front Immunol 2022;13:828875. [PMID: 35211123 DOI: 10.3389/fimmu.2022.828875] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Ouyang W, Jiang Y, Bu S, Tang T, Huang L, Chen M, Tan Y, Ou Q, Mao L, Mai Y, Yao H, Yu Y, Lin X. A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma. Front Cell Dev Biol 2022;9:758777. [DOI: 10.3389/fcell.2021.758777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tang Y, Wu Y, Xue M, Zhu B, Fan W, Li J, Granito A. A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/3822773] [Reference Citation Analysis]
4 Huang J, Zhang J, Guo Z, Li C, Tan Z, Wang J, Yang J, Xue L. Easy or Not-The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity. Front Immunol 2021;12:741302. [PMID: 34737746 DOI: 10.3389/fimmu.2021.741302] [Reference Citation Analysis]